Can't fill your Tolvaptan prescription? Learn about alternatives to Samsca and Jynarque for hyponatremia and ADPKD, including other medications and approaches.
Whether it's a supply issue, an insurance denial, or cost that's standing in the way, not being able to fill your Tolvaptan prescription can be stressful — especially when you depend on it. If you've been prescribed Samsca for hyponatremia or Jynarque for autosomal dominant polycystic kidney disease (ADPKD), you may be wondering: is there anything else that works?
The short answer is that it depends on your condition. Let's walk through what Tolvaptan does, how it works, and what alternatives exist for each approved use.
Tolvaptan is a vasopressin V2-receptor antagonist — a class of drugs sometimes called "vaptans." It's manufactured by Otsuka Pharmaceutical and sold under two brand names:
There is no generic version of Tolvaptan available in the US as of 2026, and the cash price ranges from $7,000 to $18,000 per month, making it one of the most expensive commonly prescribed specialty medications.
Tolvaptan blocks vasopressin (also called antidiuretic hormone or ADH) at V2 receptors in the kidneys. This causes your kidneys to excrete free water without losing sodium or potassium — a process called aquaresis. The result is higher serum sodium levels in patients with hyponatremia.
In ADPKD, blocking V2 receptors also reduces the production of cyclic AMP (cAMP) in kidney cells, which slows the growth of fluid-filled cysts. This helps preserve kidney function over time.
If you're taking Samsca for low sodium levels and can't access it, these are the main alternatives your doctor may consider:
Limiting fluid intake to 1,000 to 1,500 mL per day is the first-line treatment for euvolemic and hypervolemic hyponatremia. It's free, it's non-pharmacologic, and it works for many patients — though it can be difficult to sustain long-term and may not be sufficient for severe cases.
Conivaptan is another vaptan that blocks both V1A and V2 vasopressin receptors. It's given as an intravenous infusion in the hospital setting for euvolemic and hypervolemic hyponatremia. It's not a take-home option, but if you're hospitalized and Samsca isn't available, your medical team may use Conivaptan instead.
Urea is an osmotic agent that promotes water excretion by the kidneys. It's been used extensively in Europe for chronic SIADH and is gaining traction in the US. The main downsides are its bitter, unpleasant taste (often mixed in orange juice or other beverages to mask it) and the fact that it's not FDA-approved for this indication. It's available as a compounded product or through some specialty suppliers.
Demeclocycline is a tetracycline antibiotic that has an off-label use in SIADH-related hyponatremia. It works by making the kidneys less responsive to vasopressin. However, it's slower to take effect (days to weeks), can cause photosensitivity, and carries a risk of nephrotoxicity — so it's generally considered a second- or third-line option.
In mild chronic hyponatremia, supplemental sodium chloride tablets combined with fluid restriction may help maintain adequate sodium levels. This approach is simple but limited in effectiveness for more severe cases.
If you're taking Jynarque to slow the progression of polycystic kidney disease, the situation is more limited. As of 2026, Jynarque is the only FDA-approved medication specifically indicated to slow kidney function decline in ADPKD. There is no direct substitute.
However, your nephrologist may discuss:
It's important to note that stopping Jynarque abruptly without medical guidance is not recommended. Always talk to your prescriber before making changes.
If you can't fill your Tolvaptan prescription, don't panic — but don't ignore it either. Talk to your doctor as soon as possible about alternatives that might work for your specific situation. The right substitute depends on whether you're treating hyponatremia or ADPKD, and on the severity of your condition.
In the meantime, use Medfinder to check if any pharmacies near you have Tolvaptan in stock. You may also want to explore savings programs and patient assistance if cost is the barrier. And if you want to understand the medication better, read our complete guide to Tolvaptan.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
